Company intelligence / Profile preview

ResApp Health

Brisbane, Queensland, Australiabeckershospitalreview.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

ResApp developed smartphone apps that use machine learning to analyze cough, breathing, and snoring sounds for diagnosing and screening respiratory diseases. Its SleepCheckRx received FDA clearance for sleep apnea risk screening with sensitivity up to 90% for severe cases and specificity above 83%. The company’s COVID‑19 screening tool showed promising results in early clinical studies but required further validation before broad deployment. Other apps are CE marked in Europe and TGA approved in Australia.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device (smartphone-based diagnostic app)Digital biomarker technology
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ResApp Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ResApp Health.

Explore the full profile